BIOS | BioPlus Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	10.79 - 10.80
52 Week Range	10.12 - 11.68
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	5,636
Average Volume	35,934
Shares Outstanding	19,367,500
Market Cap	209,072,163
Sector	Financial Services
Industry	Shell Companies
IPO Date	2022-01-28

Valuation
Profitability
Growth
Health
P/E Ratio	51.40
Forward P/E Ratio	N/A
EPS	0.21
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA
Website	BIOS

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

BIOS's peers: CDAQ

*Chart delayed

Analyzing fundamentals for BIOS we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see BIOS Fundamentals page.

Watching at BIOS technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on BIOS Technicals page.